PHOENIX — Biologic medications sent severe asthma into remission in a substantial proportion of patients, according to a study presented here at the annual meeting of the American Academy of Allergy, Asthma & Immunology. About 35% of 908 patients who took biologic treatments for at least 12 months were able to achieve remission status, reported…
By Robert PreidtHealthDay ReporterWEDNESDAY, Jan. 26, 2022 (HealthDay News) — Although they report difficulty breathing and discomfort while wearing a face mask, most people with asthma still use them in public places during the COVID-19 pandemic, a new study finds.University of Illinois Chicago researchers conducted an online survey of more than 500 adults with asthma.…
Cryo-EM structures of CCR1–Gi complexes. Credit: Zhejiang University Asthma is one of the most common chronic respiratory diseases worldwide and its prevalence is on the rise. Epidemiological studies reveal that the incidence of asthma ranges from 1% to 18% in various countries. More than 400 million people are suffering from asthma all over the world. The…
Researchers estimate that 1.85 million new childhood asthma cases in 2019 were linked with exposure to nitrogen dioxide, a toxic gas released by diesel vehicles Health 5 January 2022 By Adam Vaughan Heavy traffic on a street in New Delhi, IndiaRaj K Raj/Hindustan Times/Getty Images About one in 12 new child asthma cases worldwide are…
Use of a leukotriene receptor antagonist (LTRA) for asthma management did not increase the risk of neuropsychiatric disease, based on data from more than 60,000 asthma patients. Although LTRAs are established as an effective drug for asthma, the US Food and Drug Administration warnings of the risk for neuropsychiatric (NP) drug reactions — including a…